United States next generation sequencing market is expected to grow at a significant rate during the forecast period. Strong economic growth of United States is enabling the concerned authorities to allocate huge funds for the research and development activities which is expected to fuel the demand for next generation sequencing in laboratories. Rise in disposable income of the consumers is increasing the healthcare expenditure of people. Next generation sequencing helps to devise effective treatments and formulate drugs with better outcomes.
High-end investments by the major players for technological advancement and use of better equipment and tools for next generation sequencing is expected to influence the market growth. Next generation sequencing is highly sensitive to variants whose frequency is low. It has the ability to sequence a large number of genes simultaneously with fast turn around time. Higher amount of data is generated within a sample of DNA than the other present technologies. Next generation sequencing is widely used for infectious disease surveillance for producing high quality results. Increasing prevalence of terminal diseases requires the effective treatment strategies which can be obtained through next generation sequencing technology.
United States next generation sequencing market is segmented into
The major players operating in the United States next generation sequencing market are Illumina, Inc., Thermo Fischer Scientific, Inc., Roche Diagnostics Corporation, Agilent Technologies, Inc., PerkinElmer Inc., Pacific Biosciences of California Inc, 10x Genomics Inc., Amgen Inc., Bio-Rad Laboratories, Inc., QIAGEN Inc., among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.
Objective of the Study
- To analyze the historical growth of the market size of United States next generation sequencing market from 2017 to 2020.
- To estimate and forecast the market size of United States next generation sequencing market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast United States next generation sequencing market based on product, technology, application, end user, regional distribution, and company.
- To identify dominant region or segment in the United States next generation sequencing.
- To identify drivers and challenges for United States next generation sequencing market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States next generation sequencing market.
- To identify and analyze the profile of leading players operating in United States next generation sequencing market.
- To identify key sustainable strategies adopted by market players in United States next generation sequencing market.
Click here to download the sample
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of service providers across the globe. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the service providers who could not be identified due to the limitations of secondary research. Market insights research analyzed the service providers, distribution channels and presence of all major players across the globe.
Market insights research calculated the market size of
Key Target Audience
- Next generation sequencing provider companies
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to next generation sequencing market.
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
| Attribute | Details |
| Base Year | 2021 |
| Historical Years | 2017 – 2020 |
| Estimated Year | 2022E |
| Forecast Period | 2023F – 2027F |
| Quantitative Units | Revenue in USD Million and CAGR for 2017-2021 and 2022E-2027F |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | - Product
- Technology
- Application
- End User
|
| Region Scope | South-Region, West-Region, Mid-West Region & Northeast-Region |
| Key Companies Profiled | Illumina, Inc., Thermo Fischer Scientific, Inc., Roche Diagnostics Corporation, Agilent Technologies, Inc., PerkinElmer Inc., Pacific Biosciences of California Inc, 10x Genomics Inc., Amgen Inc., Bio-Rad Laboratories, Inc., QIAGEN Inc. |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
